Company / Current Liabilities per Share
AIM ImmunoTech Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$9.50
FY2025
5-year range
$0.02 / $9.50
FY2021-FY2025
Trend
+4791.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share changed +4791% YoY in FY2025, a notable deviation from the 9-year average annual change of +645%.
Based on SEC 10-K filings.
9.50 in FY2025 with a 5-year CAGR of +145.7%.
Increased from $0.18 to $9.50 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +594.5%
- 5-Year CAGR
- +145.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- AIM ImmunoTech Inc.'s current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 4791.4% year-over-year.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.50 | +4791.4% |
| FY2024 | $0.19 | +7.9% |
| FY2023 | $0.18 | +534.5% |
| FY2022 | $0.03 | +77.6% |
| FY2021 | $0.02 | -85.0% |
| FY2020 | $0.11 | -89.6% |
| FY2019 | $1.02 | +532.3% |
| FY2018 | $0.16 | +43.9% |
| FY2017 | $0.11 | -5.2% |
| FY2016 | $0.12 | +889.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026